Abstract A042: Quantitative multiplex immunoprecipitation reveals distinct protein interaction networks responsible for discrepant <i>in vivo</i> activity exhibited by two second generation CD22-targeted chimeric antigen receptors
Eric Bueter, Michael C. Jensen(Seattle Children's Hospital), Julie Park(University of California, Los Angeles), Stephen E.P. Smith(University of Washington), Corinne Summers(Seattle Children's Hospital), Rebecca Gardner(Seattle Children's Hospital), Kamila Gwiazda(Seattle Children's Hospital), Colleen Annesley(Unknown), Isabella Draper, Joshua A. Gustafson(Seattle Children's Hospital)
Cited by 0
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
|New England Journal of Medicine|2016|1.8k
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
|Blood|2017|1.1k
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
|Clinical Cancer Research|2015|754